| Erin Elizabeth Guiliano Lichy, DO | |
|
930 Sw Abbey St Ste A, Newport, OR 97365-4820 | |
| (541) 265-8816 | |
| (541) 812-2069 |
| Full Name | Erin Elizabeth Guiliano Lichy |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 930 Sw Abbey St Ste A, Newport, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184079162 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | PG177146 (Oregon) | Secondary |
| 207Q00000X | Family Medicine | DO193147 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Signature Healthcare At Home | Newport, OR | Home health agency |
| Samaritan Pacific Community Hospital | Newport, OR | Hospital |
| Good Samaritan Regional Medical Center | Corvallis, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Samaritan Pacific Health Services Inc | 2466353529 | 73 |
News Archive
Lexicon Pharmaceuticals, Inc. announced today that an independent, non-profit organization will provide funding to support the Phase 2 development of LX4211 in type 1 diabetes.
Scientists from the Skoltech Center for Design, Manufacturing, and Materials (CDMM) have developed a method for designing and manufacturing complex-shaped ceramic bone implants with a controllable porous structure, which largely enhances tissue fusion efficiency.
Medical professionals have to conduct a long series of tests to assess a patient's memory impairment and cognitive skills, functional abilities, and behavioral changes to accurately diagnose Alzheimer's disease. They also have to execute costly brain imagining scans and even, sometimes, invasive cerebral spinal fluid tests to rule out other diseases. The process is laborious at best - and subjective at worst.
Lower awareness of COVID-19, poorer health and economic conditions could reduce the effectiveness of lockdowns in developing countries, according to researchers from The University of Western Australia.
According to Millennium Research Group (MRG), the optical coherence tomography market will grow at an annual rate of almost 60% through 2015, spurred by physician adoption of this new technology that was launched in the US in May 2010.
› Verified 1 days ago
| Entity Name | Samaritan Pacific Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174888010 PECOS PAC ID: 2466353529 Enrollment ID: O20040204000304 |
News Archive
Lexicon Pharmaceuticals, Inc. announced today that an independent, non-profit organization will provide funding to support the Phase 2 development of LX4211 in type 1 diabetes.
Scientists from the Skoltech Center for Design, Manufacturing, and Materials (CDMM) have developed a method for designing and manufacturing complex-shaped ceramic bone implants with a controllable porous structure, which largely enhances tissue fusion efficiency.
Medical professionals have to conduct a long series of tests to assess a patient's memory impairment and cognitive skills, functional abilities, and behavioral changes to accurately diagnose Alzheimer's disease. They also have to execute costly brain imagining scans and even, sometimes, invasive cerebral spinal fluid tests to rule out other diseases. The process is laborious at best - and subjective at worst.
Lower awareness of COVID-19, poorer health and economic conditions could reduce the effectiveness of lockdowns in developing countries, according to researchers from The University of Western Australia.
According to Millennium Research Group (MRG), the optical coherence tomography market will grow at an annual rate of almost 60% through 2015, spurred by physician adoption of this new technology that was launched in the US in May 2010.
› Verified 1 days ago
| Entity Name | Samaritan Pacific Health Services Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1801847066 PECOS PAC ID: 2466353529 Enrollment ID: O20061104000163 |
News Archive
Lexicon Pharmaceuticals, Inc. announced today that an independent, non-profit organization will provide funding to support the Phase 2 development of LX4211 in type 1 diabetes.
Scientists from the Skoltech Center for Design, Manufacturing, and Materials (CDMM) have developed a method for designing and manufacturing complex-shaped ceramic bone implants with a controllable porous structure, which largely enhances tissue fusion efficiency.
Medical professionals have to conduct a long series of tests to assess a patient's memory impairment and cognitive skills, functional abilities, and behavioral changes to accurately diagnose Alzheimer's disease. They also have to execute costly brain imagining scans and even, sometimes, invasive cerebral spinal fluid tests to rule out other diseases. The process is laborious at best - and subjective at worst.
Lower awareness of COVID-19, poorer health and economic conditions could reduce the effectiveness of lockdowns in developing countries, according to researchers from The University of Western Australia.
According to Millennium Research Group (MRG), the optical coherence tomography market will grow at an annual rate of almost 60% through 2015, spurred by physician adoption of this new technology that was launched in the US in May 2010.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin Elizabeth Guiliano Lichy, DO Po Box 2847, Corvallis, OR 97339-2847 Ph: () - | Erin Elizabeth Guiliano Lichy, DO 930 Sw Abbey St Ste A, Newport, OR 97365-4820 Ph: (541) 265-8816 |
News Archive
Lexicon Pharmaceuticals, Inc. announced today that an independent, non-profit organization will provide funding to support the Phase 2 development of LX4211 in type 1 diabetes.
Scientists from the Skoltech Center for Design, Manufacturing, and Materials (CDMM) have developed a method for designing and manufacturing complex-shaped ceramic bone implants with a controllable porous structure, which largely enhances tissue fusion efficiency.
Medical professionals have to conduct a long series of tests to assess a patient's memory impairment and cognitive skills, functional abilities, and behavioral changes to accurately diagnose Alzheimer's disease. They also have to execute costly brain imagining scans and even, sometimes, invasive cerebral spinal fluid tests to rule out other diseases. The process is laborious at best - and subjective at worst.
Lower awareness of COVID-19, poorer health and economic conditions could reduce the effectiveness of lockdowns in developing countries, according to researchers from The University of Western Australia.
According to Millennium Research Group (MRG), the optical coherence tomography market will grow at an annual rate of almost 60% through 2015, spurred by physician adoption of this new technology that was launched in the US in May 2010.
› Verified 1 days ago
Marcia Jennifer Adams, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 36 Sw Nye St, Newport, OR 97365 Phone: 541-265-6611 Fax: 541-574-6252 | |
Lawrence Kaiqi Hou, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 930 Sw Abbey St, Newport, OR 97365 Phone: 541-265-2244 | |
Sharyl Magnuson Boyle, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1010 Sw Coast Hwy Ste 203, Newport, OR 97365 Phone: 541-265-4947 Fax: 541-574-7670 | |
Andrea Kay Lind, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 705 Sw Coast Hwy, Newport, OR 97365 Phone: 541-574-4860 | |
John Baptiste Lehrer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 775 Sw 9th St, Suite G, Newport, OR 97365 Phone: 541-265-3772 | |
Patrick Brian Wood, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 930 Sw Abbey St Ste A, Newport, OR 97365 Phone: 541-265-8816 |